BRAF and glioblastoma: <h4>Background</h4>Up to 15% of young adults with glioblastoma have the activating oncogenic <i>BRAF</i> <sup>V600E</sup> mutation, an actionable target of the MAPK signal transduction pathway governing tumor cell proliferation.